Home/Filings/4/A/0001724521-24-000057
4/A//SEC Filing

Goeltz II Robert C. 4/A

Accession 0001724521-24-000057

CIK 0001724521other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:49 PM ET

Size

5.0 KB

Accession

0001724521-24-000057

Insider Transaction Report

Form 4/AAmended
Period: 2024-01-23
Goeltz II Robert C.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-01-23+22,00073,831 total
Footnotes (1)
  • [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001653881

Filing Metadata

Form type
4/A
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:49 PM ET
Size
5.0 KB